| 000 | 01875 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516052809.0 | ||
| 264 | 0 | _c20120608 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1874-4729 | ||
| 024 | 7 |
_a10.2174/1874471011205010038 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWiebe, Leonard I | |
| 245 | 0 | 0 |
_aBiochemistry and biology of 2'-Fluoro-2'-deoxythymidine (FT), a putative highly selective substrate for thymidine kinase type 2 (TK2). _h[electronic resource] |
| 260 |
_bCurrent radiopharmaceuticals _cJan 2012 |
||
| 300 |
_a38-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aAutoradiography |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aMembrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 |
_aThymidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aThymidine Kinase |
| 650 | 0 | 4 | _aTransgenes |
| 700 | 1 | _aSun, William | |
| 700 | 1 | _aZhou, Aihua | |
| 700 | 1 | _aYang, Jennifer | |
| 700 | 1 | _aSjuvarsson, Elena V | |
| 700 | 1 | _aEriksson, Staffan | |
| 700 | 1 | _aPaproski, Robert J | |
| 700 | 1 | _aCass, Carol E | |
| 700 | 1 | _aKumar, Piyush | |
| 700 | 1 | _aKnaus, Edward E | |
| 773 | 0 |
_tCurrent radiopharmaceuticals _gvol. 5 _gno. 1 _gp. 38-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1874471011205010038 _zAvailable from publisher's website |
| 999 |
_c21107032 _d21107032 |
||